# Serum Soluble Endoglin and Matrix Metalloproteinase 14 With Elisa Method in Early/Late-onset Preeclampsia

> **NCT03932877** · — · COMPLETED · sponsor: **Cengiz Gokcek Women's and Children's Hospital** · enrollment: 125 (actual)

## Conditions studied

- Preeclampsia

## Interventions

- **OTHER:** MMP-14 and s-ENG levels

## Key facts

- **NCT ID:** NCT03932877
- **Lead sponsor:** Cengiz Gokcek Women's and Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-30
- **Primary completion:** 2018-11-30
- **Final completion:** 2018-12-30
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2019-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03932877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03932877, "Serum Soluble Endoglin and Matrix Metalloproteinase 14 With Elisa Method in Early/Late-onset Preeclampsia". Retrieved via MORVS 2026-10-14 from https://api.morvs.ai/clinical/NCT03932877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*